Clinical Analysis of 896 Cases of Midtrimester Amniocentesis.
- Author:
Hyang Ah LEE
1
;
Seong Jin CHOI
;
In Bai CHUNG
;
Dong Soo CHA
;
Kyoung Hee HAN
;
Hyo Eon KIM
;
Kap Jun YOON
Author Information
1. Department of Obstetrics and Gynecology, Clinicopathology, Yonsei University, Wonju College of Medicine, Wonju, Korea.
- Publication Type:Original Article
- Keywords:
Amniocentesis;
Chromosomal abnormality
- MeSH:
Amniocentesis*;
Biomarkers;
Chromosome Aberrations;
Cytogenetics;
Female;
Gangwon-do;
Gestational Age;
Humans;
Incidence;
Maternal Age;
Mosaicism;
Pregnancy;
Pregnancy Trimester, Second*;
Retrospective Studies
- From:Korean Journal of Obstetrics and Gynecology
2003;46(11):2203-2208
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: We report our experience with midtrimester amniocentesis. METHODS: This study was retrospectively reviewed 896 cases of midtrimester genetic amniocentesis from January 1997 to October 2003 in Yonsei university, Wonju Colleage of medicine. We analyzed the indications, distributions of gestational age, cytogenetic results, and the safety. RESULTS: The most common Indications for amniocentesis were abnormal maternal serum marker (52.7%) and advanced maternal age (36.6%). Most amniocentesis has been performed during second trimester from 16 to 20 weeks. The incidence of chromosomal abnormality was 3.9% (35 cases). There were 26 cases of numerical aberration, 6 cases of structural aberration and 3 cases of mosaicism. In chromosomal aberration, there was 9.0% (2/22) of chromosomal abnormalities in abnormal ultrasonographic finding group and 6.9% (2/29) in previous chromosomal anomaly. There were 3 cases of fetal loss (0.3%) after amniocentesis. CONCLUSION: Midtrimester amniocentesis is a useful and safe technique for the prenatal detection of genetic disorder.
